$MMED News

Wells Fargo Maintains Overweight on Minimed Group, Lowers Price Target to $22

Full Transcript: Minimed Group Q4 2026 Earnings Call

Minimed Group Q4 EPS $(0.68) Misses $0.11 Estimate, Sales $837.000M Beat $789.096M Estimate

B of A Securities Maintains Buy on Minimed Group, Lowers Price Target to $20

Benchmark Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $20

MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System

MiniMed Group Announces Health Canada License New Software For MiniMed 780G System

Medtronic Reports Cybersecurity Breach, Says No Impact On Patients Or Operations

MiniMed to announce financial results for its fourth quarter and full fiscal year 2026

Is It Time To Revisit Minimed Group (MMED) After Recent Share Price Weakness?

Barclays Initiates Coverage On Minimed Group with Overweight Rating, Announces Price Target of $26

William Blair Initiates Coverage On Minimed Group with Outperform Rating

Citigroup Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $23

Piper Sandler Initiates Coverage On Minimed Group with Neutral Rating, Announces Price Target of $16

Mizuho Initiates Coverage On Minimed Group with Outperform Rating, Announces Price Target of $21

Wells Fargo Initiates Coverage On Minimed Group with Overweight Rating, Announces Price Target of $26

Morgan Stanley Initiates Coverage On Minimed Group with Overweight Rating, Announces Price Target of $19

Evercore ISI Group Initiates Coverage On Minimed Group with Outperform Rating, Announces Price Target of $20

B of A Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $27

BTIG Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $25